Maintenance therapy in NSCLC: why? To whom? Which agent?

Por Maione Paolo, Garassino Marina, Di Maio Massimo, Cortinovis Diego, Banna Giuseppe, Tiseo Marcello, Milella Michele, Novello Silvia, Martelli Olga, Vavalà Tiziana, Bria Emilio
Publicado em 2011-05-01

Maintenance therapy in NSCLC: why? To whom? Which agent?

Por Novello, Silvia, Milella, Michele, Tiseo, Marcello, Banna, Giuseppe, Cortinovis, Diego, Di Maio, Massimo, Garassino, Marina, Maione, Paolo, Martelli, Olga, Vavalà, Tiziana, Bria, Emilio
Publicado em 2011

Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)

Por Ganzinelli, Monica, Rulli, Eliana, Caiola, Elisa, Chiara Garassino, Marina, Broggini, Massimo, Copreni, Elena, Piva, Sheila, Longo, Flavia, Labianca, Roberto, Bareggi, Claudia, Agnese Fabbri, Maria, Martelli, Olga, Fagnani, Daniele, Cristina Locatelli, Maria, Bertolini, Alessandro, Valmadre, Giuseppe, Pavese, Ida, Calcagno, Anna, Giuseppa Sarobba, Maria, Marabese, Mirko
Publicado no Sci Rep (2015)